Shares of Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $10.92, but opened at $11.5690. Santen Pharmaceutical shares last traded at $11.5690, with a volume of 313 shares.
Santen Pharmaceutical Stock Up 3.2%
The firm has a fifty day moving average of $12.23 and a two-hundred day moving average of $11.71.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and commercializes prescription eye-care medicines and related products for conditions affecting vision and ocular health.
Its portfolio includes treatments for glaucoma and ocular hypertension, dry eye disease, retinal disorders, eye infections and allergies, as well as other ophthalmic conditions. Santen also conducts research in areas such as regenerative medicine and other therapies intended to address unmet needs in eye care.
Founded in Japan in 1890, Santen has expanded beyond its domestic market and serves patients and healthcare professionals across Asia, Europe and other international markets.
Further Reading
- Five stocks we like better than Santen Pharmaceutical
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
